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Abstract
Background: Environmental stress plays an important role in the development of glucose intolerance influencing
lipid and glucose metabolism through sympathetic nervous system, cytokines and hormones such as
glucocorticoids, catecholamines and glucagon. Otherwise, fish oil prevents glucose intolerance and insulin
resistance. Although the mechanisms involved are not fully understood, it is known that sympathetic and HPA
responses are blunted and catecholamines and glucocorticoids concentrations can be modulated by fish
consumption. The aim of the present study was to evaluate whether fish oil, on a normal lipidic diet: 1) could
prevent the effect of footshock-stress on the development of glucose intolerance; 2) modified adiponectin receptor
and serum concentration; and 3) also modified TNF-a, IL-6 and interleukin-10 (IL-10) levels in adipose tissue and
liver. The study was performed in thirty day-old male Wistar randomly assigned into four groups: no stressed (C)
and stressed (CS) rats fed with control diet, and no stressed (F) and stressed (FS) rats fed with a fish oil rich diet.
The stress was performed as a three daily footshock stress sessions.
Results: Body weight, carcass fat and protein content were not different among groups. FS presented a reduction
on the relative weight of RET. Basal serum glucose levels were higher in CS and FS but 15 min after glucose load
just CS remained with higher levels than other groups. Serum corticosterone concentration was increased in CS,
this effect was inhibited in FS. However, 15 min after footshock-stress, corticosterone levels were similar among
groups. IL-6 was increased in EPI of CS but fish oil consumption prevented IL-6 increase in FS. Similar levels of
TNF-a and IL-10 in RET, EPI, and liver were observed among groups. Adipo R1 protein concentration was not
different among groups. Footshock-stress did not modify AdipoR2 concentration, but fish oil diet increases
AdipoR2 protein concentration.
Conclusions: Footshock-stress promotes glucose intolerance associated to corticosterone serum level and
epididymal white adipose tissue IL-6 concentration increase. The fish oil consumption by stressed rats normalized
the stress responses. These results suggested that fish oil intake could be useful to minimize or prevent the
development of diseases associated to the stress.
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Background
Among environmental factors, stress plays an important
role in the induction of glucose intolerance. There are
two major components of the stress response: the auto-
nomic nervous system and the hypothalamic-pituitary-
adrenal axis (HPA) [1].
The regulation of glucose and lipid metabolism is
under the influence of the sympathetic nervous system,
cytokines [2], and increased plasmatic levels of glucocor-
ticoids and glucagon acting synergistically with the cate-
cholamines to increase glycemia during stress [3].
Corticosterone, in rodents, is a hormone released by
adrenal cortex after the activation of HPA axis [1] and
increases glucose production by the liver and decreased
peripheral glucose transport and utilization [4].
Glucocorticoids cause a decrease in adipocyte gene
expression and secretion of adiponectin and interleukin-
6 (IL- 6) [5,6]. On the other hand, in primary cultures
of murine adipocytes, norepinephrine, isoprenaline, and
a b3-selective agonist have been shown to stimulate IL-
6 gene expression and protein secretion [6].
Moreover, pro-inflammatory adipokines, such as tumor
necrosis factor- a (TNF-a) and IL-6 lead to the develop-
ment of insulin resistance [7,8]. Conversely, adiponectin
(anti-inflammatory adipokine), binding to its receptors
expressed in fat, liver and muscle tissues, activates several
intracellular signaling pathways and improves insulin sen-
sitivity, promoting glucose utilization, increasing fatty
acid oxidation and, glucose uptake in the muscle, and
reducing gluconeogenesis in the liver [9].
Previously, we have shown that three daily sessions of
foot-shock stress in rat caused an increase in the plasma
corticosterone, insulin and glucose levels accompanied
by insulin resistance in isolated white adipocytes and
soleus muscle. These results demonstrated that foot-
shock stress could be a useful model for studying glu-
cose intolerance and insulin resistance [10,11].
Several studies have been shown that fish oil could
prevent glucose intolerance and insulin resistance
[12,13]. It has been demonstrated in both human
[14-16] and animals models [17-19] the beneficial anti-
stress effects of fish oil on stress response. The mechan-
isms by which fish oil consumption exerts the anti-stress
effect are not fully understood. But it is known that
sympathetic and HPA response are blunted [14] and
fish oil can modulate catecholamines and glucocorti-
coids concentrations [15,16].
The majority of the research, about the effects of fish
oil on glucose tolerance and insulin resistance, utilized a
high fat diet or additional supplementation. In these
sense, the aim of the present study was to evaluate
whether fish oil, on a normal lipidic diet: 1) could pre-
vent the effect of footshock-stress on the development
of glucose intolerance; 2) modified adiponectin receptor
and serum concentration; and 3) also modified TNF-a,
IL-6 and interleukin-10 (IL-10) levels in adipose tissue
and liver. These results could contribute to identify
whether a normal lipidic diet rich in n-3 polyunsatu-
rated fatty acid ameliorate the effects of stress on adipo-
kines and on glucose intolerance.
Materials and methods
Animal care
All procedures for the care of the animals used in this
study were previously approved by the Experimental
Research Committee of the Federal University of São
Paulo (protocol n°2007/1346). Twenty-four male Wistar
rats (Rattus norvegicus) were housed collectively (4 rats/
cage) after weaning until 93 d of life in a light (12 h
light/dark cycle) and temperature (24 ± 1°C) controlled
room. Diet and water were available ad libitum. Body
weight and food intake were recorded weekly.
Animals were randomly divided into 4 experimental
groups: Soybean Non stressed (C), received a diet con-
taining soybean oil as a source of lipids; Fish Oil Non
stressed (F), received a diet containing fish oil as a
source of lipids; Soybean Stressed (CS), received a diet
containing soybean oil as fat source and were submitted,
in the 91st to 93rd days of life, to the footshock-stress;
and Fish Oil Stressed (FS), received a diet containing
fish oil as fat source and were submitted to the foot-
shock-stress sessions.
Diet composition
After weaning until 60 d of life the rats were feed with
growth diet (AIN-93G), containing 20% protein and 8%
lipids, as described by American Institute of Nutrition
(AIN-93) [20]. After 60 d of life, until 93 d of life rats
were fed with a maintenance diet (AIN -93M), with 5%
lipids and 14% protein. C and CS diet contained soy-
bean oil (Liza®, Itumbiara-GO, Brazil) as lipid source.
While F and FS diet contained fish oil as lipid source
(Campestre®, São Bernardo do Campo-SP, Brazil).
Stress Procedure
Each rat underwent three daily sessions of unsignaled,
inescapable footshocks. The animals were placed in
a Plexiglas chamber (26 × 21 × 26 cm) provided with a
grid floor made of stainless-steel rods (0.3 cm in dia-
meter and spaced 1.0 cm apart). During the 30 min ses-
sions, which occurred between 8:00 and 10:30 am, the
footshocks were delivered by a constant current source
controlled by a microprocessor, with constant intensity
of 1.0 mA, with a duration of 1 s at random intervals of
5-25 s (mean interval of 15 s) [11]. In the first and sec-
ond sessions of stress the rats were at the fed state. At
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the third session of stress, rats were fasted for 12 h to
perform the Oral Glucose Tolerance Test (OGTT) after
the last session of stress.
Oral glucose tolerance test (OGTT)
After 12 h fasting, body weight recording and the third
footshock-stress session for the stressed rats (CS and
FS), all groups were submitted to OGTT. The test
started with collection of blood samples through a small
incision in tail to determine baseline parameters. Glu-
cose solution (50% glucose dissolved in saline 0.9%) was
administered by intragastric gavage (2 mL/kg). Blood
samples were collected at 15, 30, 45, 60 and 90 minutes
after glucose load. Throughout the procedure animals
were awake and free moving in the cage. To calculate
area under the curve (AUC) we used Matthews et al.
[21] formula’s: AUC = 1/2
∑n−1
i=0
(ti + 1 − ti) (yi + yi+1);
where “t” means time and “y” concentration.
Biochemical and Hormonal serum analysis
Blood samples collected after the last stress session and
before the glucose load administered in the OGTT was
used to evaluate the baseline blood glucose, adiponectin
and insulin concentration. Serum Insulin (R&D Sys-
tems®, Minneapolis-MN, USA), adiponectin (R&D Sys-
tems®, Minneapolis-MN, USA) and corticosterone
(Stressgen®, Ann Harbor-MI, USA) concentrations and
TNF-a, IL-6 and IL-10 (R&D Systems®, Minneapolis-
MN, USA) in adipose tissue and liver levels were deter-
mined by enzyme-linked immunosorbent assay (ELISA).
Glucose was determined with the commercially available
kit PAP Liquiform Glucose (Labtest®, Lagoa Santa-MG,
Brazil). Protein was quantified with the BCA Reagent
for proteins - Lowry Modified (BioAgency®, São Paulo-
SP, Brazil).
Carcass lipid and protein content
Carcasses were eviscerated, weighed, and stored at -20°
C. Lipid content was measured as described by Stansbie
et al. [22] and standardized using the method described
by do Nascimento and Williamson [23]. Briefly, the evis-
cerated carcass was autoclaved at 120°C for 90 min and
homogenized with double the mass of water. Triplicate
aliquots of this homogenate were weighed and digested
in 3 ml of 30% KOH and 3 ml of ethanol for at least 2
h at 70°C in capped tubes. After cooling, 2 ml of 12 N
H2SO4 were added and the sample was washed three
times with petroleum ether for lipid extraction. Results
are expressed as grams of lipid per 100 g of carcass. For
protein measurements, aliquots of the same homogenate
were heated to 37°C for 1 hour in 0.6 N KOH with con-
stant shaking. After clarification by centrifugation, pro-
tein content was quantified.
Western blotting procedures
Animals were decapitated. Retroperitoneal (RET) and
epididymal (EPI) adipose tissues and liver were removed
and homogenized in ice-cold solubilization and total
protein extraction buffer (100 mM Tris, pH 7.5, 10 mM
ethylene acetic acid, 100 mM sodium fluoride, 10 mM
sodium orthovanadate, 2 mM phenylmethylsulfonyl
fluoride, 10 mM sodium pyrophosphate and 0.1 mg/mL
aprotinin. After homogenization, Triton X-100 was
added, to a final concentration of 1%. Samples rested in
ice for 30 min and were clarified by centrifugation.
Equal amounts of protein (30 μg for liver and 120 μg
for RET and EPI) were loaded in 10% sodium dodecyl-
sulfate polyacrylamide gel electrophoresis, electrophore-
tically separated, and transferred to nitrocellulose
membranes. Membranes were incubated with the appro-
priate primary antibody: AdipoR1 (SC-46748), AdipoR2
(SC-46751), HSD1 (SC-20175) and a-tubulin (SC-
58664) (Santa Cruz Biotechnology®, Santa Cruz-CA,
USA). After secondary antibody incubation, detection
was performed by chemiluminescence with an enhanced
chemiluminescence reagent (Amersham Biosciences®,
Piscataway-NJ, USA). Membranes were stripped and
reblotted with a-tubulin. Quantitative analyses were per-
formed with ImageJ® software and the results as stan-
dardized with a-tubulin as load control. Data are
expressed as percentage (%) of control.
Data analysis
The results are expressed as mean ± SEM. For multiple
comparisons of means was performed analysis of var-
iance (ANOVA) two-way with subsequent use of the
Tukey post-hoc test. Statistical significance was set at
P <0.05.
Results
General characteristics of the experimental groups
Body weight, carcass fat and protein content (Table 1)
and food intake (data not showed) were similar among
all groups.
Neither footshock-stress nor fish oil consumption
altered relative weight of RET, EPI and liver. However,
the association of fish oil consumption and footshock-
stress reduced the relative weight of RET in relation
to C, with no differences in EPI and liver (Table 1).
OGTT and Biochemical and Hormonal serum analysis
Basal serum glucose levels were higher in stressed (CS
and FS) than in non stressed (C and F) animals. How-
ever, 15 min after glucose load, CS serum glucose levels
remained elevated compared to other groups, but fish
oil ingestion abolished the effect of footshock-stress on
glucose levels (Figure 1A). Conversely, glucose AUC was
similar among groups (Figure 1B).
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Table 1 Animal characteristics from body composition, serum basal levels of adiponectin, insulin, glucose and
corticosterone of Control (C), Stressed (CS), Fish Oil (F) and Fish oil Stressed (FS) groups
C CS F FS p
Initial body weight (g) 94.6 ± 3.4 94.6 ± 5.1 91.9 ± 3.9 92.2 ± 3.2 ns
Final body weight (g) 369.2 ± 9.3 373.3 ± 10.9 376.9 ± 9.5 361.6 ± 10.2 ns
Carcass content
Protein (g/100 g) 16.3 ± 1.6 16.9 ± 0.9 17.1 ± 1.8 18.9 ± 1.5 ns
Fat (g/100 g) 8.6 ± 1.0 8.8 ± 1.2 7.7 ± 1.2 8.0 ± 1.1 ns
Relative weight
RET (g/100 g) 2.00 ± 0.17 1.54 ± 0.15 1.48 ± 0.09 1.24 ± 0.17* 0.05
EPI (g/100 g) 2.12 ± 0.20 1.97 ± 0.18 1.71 ± 0.26 1.43 ± 0.11 ns
LIV (g/100 g) 2.88 ± 0.05 2.83 ± 0.13 2.91 ± 0.08 2.65 ± 0.03 ns
Adiponectin (mg/mL) 7.34 ± 0.56 8.04 ± 0.71 7.57 ± 0.54 7.49 ± 0.58 ns
Insulin (ng/mL) 1.01 ± 0.37 0.96 ± 0.29 0.75 ± 0.16 0.67 ± 0.21 ns
Glucose (mg/dL) 95.1 ± 3.4 133.4 ± 10.1§ 93.5 ± 3.0 125.19 ± 6.0§ 0.0001
Corticosterone (ng/mL) 182.0 ± 23.5 376.1 ± 40.1* 122.2 ± 9.1 108.8 ± 42.7 0.04
Data are means ± SEM. N = 6 rats/group. * Different from Control (C) group p < 0.05. § Different from Control (C) and Fish Oil (F) groups p < 0.05.
Figure 1 OGTT-Oral Glucose Tolerance Test (A), glucose AUC (B) serum corticosterone levels (C) and corticosterone AUC (D) of Control
(C), Stressed (CS), Fish Oil (F) and Fish oil Stressed (FS) groups. Data are means ± SEM. N = 6 rats/group. * Different from Control (C) group
p < 0.05. † Stressed rats (CS) different from non stressed rats (C and F). § Footshock-stressed rats (CS and FS) different from non stressed rats (C
and F) p < 0.05. # Different from all other groups p < 0.05.
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Insulin and adiponectin serum concentration were
similar among groups (Table 1).
Immediately after footshock-stress, serum corticoster-
one concentration was increased in CS, but fish oil diet
inhibits this effect (FS) (Table 1). 15 min after footshock-
stress session, corticosterone levels were similar among
groups (Figure 1C). Still, CS corticosterone AUC was
higher than the others groups (C, F and FS) (Figure 1D).
IL-6, TNF-a. and IL-10 levels in RET, EPI and liver
Footshock-stress (CS) lead to an increase of IL-6 levels
in EPI compared to C. Fish oil consumption (F) did not
alter IL-6 levels and prevented IL-6 increase in foot-
shock-stressed animals (FS) (figure 2C). Similar levels of
TNF-a and IL-10 in RET, EPI, and liver were observed
among groups (figure 2A, B).
AdipoR1/R2 quantity in adipose tissue and liver
Adipo R1 protein concentration was similar in the study
tissues among groups (Figure 3A). The footshock-stress
did not modify AdipoR2 concentration in studied
groups. Although, fish oil diet increases AdipoR2 pro-
tein concentration in RET as compared to control diet
(F vs. C) (Figure 3B).
Discussion
The present study shows that footshock-stress caused a
glucose intolerance accompanied by an increase in corti-
costerone level and IL-6 epididymal protein content.
The fish oil consumption blunted these effects of stress,
demonstrating the preventive effect of fish oil consump-
tion in development of glucose intolerance promoted by
footshock-stress.
The final body weight and carcasses lipid and protein
content were not modified by 3 days of footshock-stress
and/or fish oil consumption for 8 weeks. Previously,
Papakonstantinou et al. [24], using a repeated restraint
stress for 3 days, 3 hours per day, showed that con-
sumption of hyperlipidic diet rich with fish oil (2 weeks
Figure 2 TNF-a (A), IL-10 (B) and, IL-6 (C) protein contents in
retroperitoneal (RET), epididymal (EPI) adipose tissues and liver
of Control (C), Stressed (CS), Fish Oil (F) and Fish oil Stressed
(FS) groups. Data are means ± SEM. N = 6 rats/group. * Different
from Control (C) group p < 0.05.
Figure 3 AdipoR1(A) and AdipoR2 (B) protein contents in
retroperitoneal (RET), epididymal (EPI) adipose tissues and liver
of Control (C), Stressed (CS), Fish Oil (F) and Fish oil Stressed
(FS) groups. Results were quantified by densitometry and a-tubulin
was used as load control. Data are expressed as % of control (C)
and are means ± SEM. N = 6 rats/group. * Different from Control
(C) group p < 0.05.
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before stress and 2 after) did not ameliorate stress-
induced anorexia and weight loss. Similar results was
observed in rats treated with normolipidic diet contain-
ing fish oil for 45 days submitted for 96 hours of sleep
deprivation [25]. Taken these results all together it
could be suggested that the duration of fish oil ingestion
and type of stressor could influence the effect of stress
in body weight.
However, in the present study the footshock-stress in
fish oil treated rats caused a decrease in RET weight.
Fish oil reduces fatty acid accumulation [26,27] and
prevents diet induced obesity [28], mainly through the
regulation of lipid metabolism by inhibiting lipogenesis,
promoting lipolysis and fatty acid oxidation, and
suppressing preadipocyte differentiation [29].
As previously reported [10,11] footshock-stress caused
a glucose intolerance and increase corticosterone serum
levels, in addition in the present study we demonstrated
that the ingestion for 8 weeks of normolipidic diet rich
in fish oil prevented these effects.
Insulin resistance promoted by glucocorticoid has long
been known and is associated with increased hepatic
glucose production and decreased peripheral glucose
transport and utilization [4]. In the present study, CS
exhibited a marked increase in corticosterone concentra-
tions in relation to all other groups, including FS, which
reflects OGTT response. This result suggests that glu-
cose intolerance promoted by footshock occurred in
response to activation of HPA axis, and that consump-
tion of fish oil blunted this effect, protecting against glu-
cose intolerance. This result underscores the anti-stress
effect of fish oil consumption.
Based on these find, we seek to establish whether the
effect of fish oil was not only related to the normal cor-
ticosterone level observed in FS group, but also if it
could be associated to fish oil effects on adipokines
related to glucose intolerance.
The increase in adipoR2 in fish oil fed rats might be
involved in this response, but further investigations will
be required to elucidate the mechanisms involved.
The insulin-sensitizing adipokine adiponectin is
another important factor involved in glucose intolerance
[30,31]. Adiponectin is specifically expressed in adipose
tissue and has antiatherogenic and antidiabetic proper-
ties [31-33] and its effects are mediated by adiponectin
receptors, adipoR1 and adipoR2 [32]. AdipoR1 is abun-
dantly expressed in skeletal muscle, whereas adipoR2 is
predominantly found in liver [31,32] and both are also
expressed in adipose tissue [32].
The effects of stress and glucocorticoids on adiponec-
tin regulation are controversial. In human adipocytes,
dexamethasone inhibits adiponectin release [34]. In
human volunteers treated with dexamethasone plasma
adiponectin levels were unchanged [35], while in
another study a small rise was found [36] but adiponec-
tin was decreased in subjects treated with hydrocorti-
sone [37]. Catecholamine also modulates adiponectin,
b-adrenergic stimulation downregulate adiponectin gene
expression [30,38] but upregulates AdipoR2 expression
[30]. These data suggest that fish oil consumption,
although not alter serum levels of adiponectin, may have
improved the sensitivity to this hormone contributing to
the protective effect of fish oil on glucose intolerance
induced by stress.
Increase in pro-inflammatory adipokines, such as
TNF-a and IL-6, also leads to glucose intolerance and
insulin resistance [7].
The fish oil and stress have been reported to exert pro
and anti-inflammatory effects [29,39]. In these sense, we
decided to measured the retroperitoneal and epididymal
white adipose tissue and liver TNF-a, IL-6 and IL-10
protein content.
Neither footshock-stress, fish oil consumption nor the
interaction between fish oil and footshock-stress caused
modification on TNF-a and IL-10 protein content in
the studied tissues. However, the footshock-stress
increased IL-6 protein concentration in EPI and fish oil
consumption impaired this effect.
Glucocorticoids cause a decrease in adipocyte gene
expression and secretion of adiponectin and IL- 6 [5,6].
On the other hand, in primary cultures of murine adipo-
cytes, norepinephrine, isoprenaline, and a b3-selective
agonist have been shown to stimulate IL-6 gene expres-
sion and protein secretion [6]. Conversely, fish oil rich
diet decreased plasma levels of norepinephrine in
healthy subjects [40]. In the present study, the decrease
in EPI IL-6 protein content in FS group is not related to
an increase in glucocorticoid, since stress did not modi-
fied this hormone concentration in fish oil treated rats.
However, taken our results with the literature ones, the
decrease in IL-6 could be related to a decrease in nore-
pinephrine caused by fish oil diet in stressed rats (FS).
The catecholamines were not evaluated, which is a lim-
iting factor in this study, since these hormones, like cor-
ticosterone, reflect the stress response and affects many
metabolic effects. However the measurement of serum
corticosterone demonstrated its important role in the
footshock-stress and fish oil consumption response.
Adipose tissue IL-6 production may account for about
25% of the circulating IL-6 [41]. Then, the decrease in
IL-6 in EPI of FS comparing to CS reflect, probably, in
the serum IL-6 concentration and in the normal glucose
tolerance test observed in FS rats in relation to CS rats.
In summary, footshock-stress promoted glucose intol-
erance associated to corticosterone serum level and
epididymal white adipose tissue IL-6 concentration
increase. The fish oil consumption by stressed rats nor-
malized the stress responses. These results suggested
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that fish oil intake could be useful to minimize or
prevent the development of diseases associated to the
stress.
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